The global micro-pumps market size was valued at USD 2.19 billion in 2023 and is anticipated to grow at a CAGR of 17.7% from 2024 to 2030. The market growth is driven by the rising number of pharmaceutical industries, and increased research and development in life sciences are significantly boosting demand. Additionally, the development and adoption of clinical tests and the high use of micro-pumps in infusion therapy are crucial drivers. The increasing prevalence of chronic diseases such as diabetes and cancer, coupled with the growing geriatric population, further fuels the market expansion.
Technological advancements and innovations in micro-pump designs also play a vital role in enhancing their applications in minimally invasive surgical procedures and drug delivery systems. The current focus is on making medical devices smaller to improve portability and patient comfort. The rising use of point-of-care testing (POCT) kits and lab-on-chip applications is also contributing to market expansion. Additionally, there is a growing adoption of smart micro-pumps integrated with IoT for real-time monitoring and control. The market is also expected to benefit from increased research and development activities in the pharmaceutical sector and a greater emphasis on personalized medicine.
The mechanical micro-pumps segment held 56.2% of the revenue share in 2023 attributed to its widespread application in various medical and industrial fields. Mechanical micro-pumps, which include piezoelectric, electrostatic, and electromagnetic pumps, are favored for their simplicity in design, reliability, and ability to generate higher pressure. These pumps are extensively used in drug delivery systems, infusion therapy, and diagnostic devices, where precise fluid control is crucial.
The non-mechanical micro-pumps segment is projected to grow at a CAGR of 17.5% from 2024 to 2030. Non-mechanical micro-pumps offer advantages such as reduced wear and tear, lower maintenance, and the ability to handle smaller volumes of fluids with high precision. These attributes make them highly suitable for applications in biotechnology, pharmaceuticals, and environmental monitoring. The increasing focus on lab-on-chip technologies and point-of-care diagnostics is driving the demand for non-mechanical micro-pumps.
The drug delivery segment dominated the global micro-pumps market in 2023, driven by the increasing demand for precise and controlled drug administration. Micro-pumps are extensively used in various drug delivery systems, including insulin pumps for diabetes management, pain management devices, and infusion pumps for chemotherapy. The ability of micro-pumps to deliver accurate dosages with minimal invasiveness makes them highly suitable for chronic disease management and personalized medicine. Additionally, advancements in micro-pump technology, such as the development of smart pumps with integrated sensors and connectivity features, are enhancing their efficiency and patient compliance.
The in-vitro diagnostics (IVD) segment is projected to be the fastest-growing application segment from 2024 to 2030. This growth is primarily attributed to the increasing adoption of point-of-care testing (POCT) and lab-on-chip technologies, which require precise fluid handling capabilities provided by micro-pumps. Micro-pumps play a crucial role in IVD devices by enabling accurate sample preparation, reagent mixing, and fluid transport. The rising demand for rapid and accurate diagnostic tests has accelerated the adoption of micro-pumps in IVD applications.
The biotechnology and pharmaceutical companies segment held the largest revenue share in the global micro-pumps market in 2023 primarily due to the extensive use of micro-pumps in drug discovery, development, and delivery processes. The ability of micro-pumps to deliver accurate and controlled volumes of fluids makes them indispensable in these industries, where precision and reliability are critical. Additionally, the increasing investment in research and development by pharmaceutical companies to develop new therapies and drugs further drives the demand for advanced micro-pump technologies.
The hospital and diagnostic center segment is expected to grow substantially over the forecast period. This growth is driven by the rising adoption of micro-pumps in various medical applications, including infusion therapy, diagnostic testing, and patient monitoring. Hospitals and diagnostic centers are increasingly utilizing micro-pumps for their ability to provide precise and reliable fluid delivery, which is essential for accurate diagnostic results and effective patient care. Furthermore, the increasing demand for POCT and minimally invasive procedures is expected to boost the adoption of micro-pumps in these settings.
North America held a 49.8% revenue share in 2023 attributed to the region’s advanced healthcare infrastructure, high adoption rate of innovative technologies, and substantial investments in research and development. The presence of major market players and a strong focus on miniaturization in medical devices further boost the market’s growth in this region.
The U.S. was the leading contributor to the North American micro-pumps market in 2023. The country’s dominance is driven by its robust healthcare system, extensive research activities, and the presence of key industry players. Additionally, the U.S. government’s support for technological advancements and favorable regulatory policies have played a crucial role in fostering market growth.
The micro-pumps market in Europe is expected to grow steadily over the forecast period. Factors such as increasing healthcare expenditure, rising demand for minimally invasive surgeries, and the presence of a well-established medical device industry contribute to this growth. The region’s focus on innovation and the development of new applications for micro-pumps in various sectors also support market expansion.
The UK emerged as a lucrative region within the European micro-pumps market in 2023. The UK’s strong healthcare infrastructure and significant investments in medical technology have driven market growth. Additionally, the country’s emphasis on research and development and supportive government policies have created a favorable environment for the micro-pumps market.
The Asia Pacific micro-pumps market is projected to grow at the fastest rate from 2024 to 2030. This rapid growth is fueled by increasing healthcare needs, rising disposable incomes, and expanding healthcare infrastructure in countries such as China and India. The region’s focus on technological advancements and the growing demand for precision medical devices further contribute to the market’s expansion.
China dominated the Asia Pacific micro-pumps market in 2023 driven by its large population, growing healthcare sector, and significant investments in medical technology. China’s emphasis on innovation and the development of advanced medical devices has also played a crucial role in its market dominance. Government initiatives to improve healthcare access and quality have further supported market growth.
Some of the major companies in the global micro-pumps market include Bartels Mikrotechnik GmbH, Bürkert Fluid Control Systems, TOPS Industry, The Lee Company, and Xiamen AJK Technology. These companies are focusing on expanding their product portfolios through technological advancements, strategic collaborations, mergers, and acquisitions. Additionally, companies are emphasizing the development of more efficient and user-friendly micro-pump systems to enhance various applications in the medical, pharmaceutical, and industrial sectors.
Bartels Mikrotechnik GmbH is a key player in the global micro-pumps market, known for its innovative microfluidic solutions. Their flagship product line, the mp6 series, includes miniaturized double diaphragm pumps designed for transporting small quantities of gases and liquids.
Bürkert Fluid Control Systems offers a comprehensive range of microfluidic products, including micro valves and diaphragm pumps. Their solutions are designed for precise and reliable handling of small volumes of liquids. Bürkert’s product offerings include 2/2 and 3/2 way micro solenoids, membrane pumps, and time-pressure dosing systems, which are widely used in clinical diagnostics, pharmaceuticals, and other industries.
The following are the leading companies in the micro-pumps market. These companies collectively hold the largest market share and dictate industry trends.
Report Attribute |
Details |
Market size value in 2024 |
USD 2.56 billion |
Revenue forecast in 2030 |
USD 6.79 billion |
Growth rate |
CAGR of 17.7% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
November 2023 |
Quantitative units |
Volume in kilotons, revenue in USD million/billion, and CAGR from 2024 to 2030 |
Report coverage |
Volume & revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end use |
Key companies profiled |
Bartels Mikrotechnik GmbH; Bürkert Fluid Control Systems; TOPS INDUSTRY & TECHNOLOGY CO., LTD.; The Lee Company; Xiamen AJK Technology Co., Ltd.; Xavitech; ALLDOO Micropump; Servoflo Corporation; Dolomite Microfluidics(Backtrace Holdings Ltd.); TTp ventus; Arcmed Group (Halma) |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue & volume growth of the micro-pumps market and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global agrochemicals market report based on product, application, and end use:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Mechanical
Non-mechanical
Application Outlook (Revenue, USD Million, 2018 - 2030)
Drug Delivery
In-vitro Diagnostics
Medical Devices
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Biotechnological & Pharmaceutical Companies
Hospitals & Diagnostic Centers
Academic & Research Institutes
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."